company background image
003020 logo

Hefei Lifeon Pharmaceutical SZSE:003020 Stock Report

Last Price

CN¥19.25

Market Cap

CN¥3.7b

7D

1.1%

1Y

-20.9%

Updated

22 Nov, 2024

Data

Company Financials +

Hefei Lifeon Pharmaceutical Co., Ltd.

SZSE:003020 Stock Report

Market Cap: CN¥3.7b

003020 Stock Overview

Engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients. More details

003020 fundamental analysis
Snowflake Score
Valuation5/6
Future Growth3/6
Past Performance3/6
Financial Health6/6
Dividends4/6

Hefei Lifeon Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Hefei Lifeon Pharmaceutical
Historical stock prices
Current Share PriceCN¥19.25
52 Week HighCN¥26.50
52 Week LowCN¥13.74
Beta0.22
11 Month Change2.39%
3 Month Change10.06%
1 Year Change-20.89%
33 Year Change-12.84%
5 Year Changen/a
Change since IPO17.20%

Recent News & Updates

Why Hefei Lifeon Pharmaceutical's (SZSE:003020) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 05
Why Hefei Lifeon Pharmaceutical's (SZSE:003020) Shaky Earnings Are Just The Beginning Of Its Problems

Hefei Lifeon Pharmaceutical (SZSE:003020) Has A Somewhat Strained Balance Sheet

Sep 30
Hefei Lifeon Pharmaceutical (SZSE:003020) Has A Somewhat Strained Balance Sheet

Recent updates

Why Hefei Lifeon Pharmaceutical's (SZSE:003020) Shaky Earnings Are Just The Beginning Of Its Problems

Nov 05
Why Hefei Lifeon Pharmaceutical's (SZSE:003020) Shaky Earnings Are Just The Beginning Of Its Problems

Hefei Lifeon Pharmaceutical (SZSE:003020) Has A Somewhat Strained Balance Sheet

Sep 30
Hefei Lifeon Pharmaceutical (SZSE:003020) Has A Somewhat Strained Balance Sheet

Hefei Lifeon Pharmaceutical (SZSE:003020) Has Announced A Dividend Of CN¥0.50

May 23
Hefei Lifeon Pharmaceutical (SZSE:003020) Has Announced A Dividend Of CN¥0.50

Investors Still Aren't Entirely Convinced By Hefei Lifeon Pharmaceutical Co., Ltd.'s (SZSE:003020) Earnings Despite 25% Price Jump

May 22
Investors Still Aren't Entirely Convinced By Hefei Lifeon Pharmaceutical Co., Ltd.'s (SZSE:003020) Earnings Despite 25% Price Jump

Hefei Lifeon Pharmaceutical's (SZSE:003020) Profits May Not Reveal Underlying Issues

Apr 29
Hefei Lifeon Pharmaceutical's (SZSE:003020) Profits May Not Reveal Underlying Issues

Shareholder Returns

003020CN PharmaceuticalsCN Market
7D1.1%-1.5%-2.1%
1Y-20.9%-9.4%2.8%

Return vs Industry: 003020 underperformed the CN Pharmaceuticals industry which returned -4.8% over the past year.

Return vs Market: 003020 underperformed the CN Market which returned 5.4% over the past year.

Price Volatility

Is 003020's price volatile compared to industry and market?
003020 volatility
003020 Average Weekly Movement6.4%
Pharmaceuticals Industry Average Movement7.3%
Market Average Movement8.3%
10% most volatile stocks in CN Market12.6%
10% least volatile stocks in CN Market5.6%

Stable Share Price: 003020 has not had significant price volatility in the past 3 months compared to the CN market.

Volatility Over Time: 003020's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20021,315Huanxi Cuiwww.lifeonapi.com

Hefei Lifeon Pharmaceutical Co., Ltd. engages in the research, development, production, and sale of pharmaceutical preparations and active pharmaceutical ingredients. It operates through Pharmaceutical Industry, Pharmaceutical Wholesale and Distribution, and Pharmaceutical Retail Business segments. The company offers active pharmaceutical ingredients, which include nifedipine, paliperidone, prilocaine, methylphenidate hydrochloride, dimercaptosuccinic acid, doxazosin mesylate, paeonol, urea, felodipine, and troxerutin; and medical preparations, such as osmotic pump preparations, central nervous systems, Chinese patent medicines, eye drops, external use, and general oral medicines.

Hefei Lifeon Pharmaceutical Co., Ltd. Fundamentals Summary

How do Hefei Lifeon Pharmaceutical's earnings and revenue compare to its market cap?
003020 fundamental statistics
Market capCN¥3.69b
Earnings (TTM)CN¥174.28m
Revenue (TTM)CN¥1.50b

21.2x

P/E Ratio

2.5x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
003020 income statement (TTM)
RevenueCN¥1.50b
Cost of RevenueCN¥455.13m
Gross ProfitCN¥1.05b
Other ExpensesCN¥871.99m
EarningsCN¥174.28m

Last Reported Earnings

Sep 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)0.91
Gross Margin69.69%
Net Profit Margin11.61%
Debt/Equity Ratio3.1%

How did 003020 perform over the long term?

See historical performance and comparison

Dividends

2.2%

Current Dividend Yield

46%

Payout Ratio